West Pharmaceutical Servi... (WST)
undefined
undefined%
At close: undefined
335.90
0.93%
Pre-market Jan 07, 2025, 04:02 AM EST

West Pharmaceutical Services Inc. Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Mar 31, 2023Dec 31, 2022Mar 31, 2022Dec 31, 2021Mar 31, 2021
Contract Manufactured Products Revenue 145.50M 142.40M 135.90M 419.00M 133.50M 361.70M 118.70M 387.60M 127.10M
Contract Manufactured Products Revenue Growth +2.18% +4.78% -67.57% +213.86% -63.09% +204.72% -69.38% +204.96% n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014Dec 31, 2013Dec 31, 2012
France Revenue 282.90M 237.90M 213.00M 172.70M 150.60M 127.50M 125.60M 116.30M 107.60M 118.20M 112.60M 102.60M
France Revenue Growth +18.92% +11.69% +23.34% +14.67% +18.12% +1.51% +8.00% +8.09% -8.97% +4.97% +9.75% n/a
Germany Revenue 406.10M 398.70M 474.30M 282.10M 236.30M 235.90M 226.40M 200.60M 194.00M 219.40M 219.60M 184.40M
Germany Revenue Growth +1.86% -15.94% +68.13% +19.38% +0.17% +4.20% +12.86% +3.40% -11.58% -0.09% +19.09% n/a
Ireland Revenue 285.70M 240.30M 247.60M 226.00M 173.80M 766.10M 734.60M 738.30M 667.40M 655.50M 614.50M 592.80M
Ireland Revenue Growth +18.89% -2.95% +9.56% +30.03% -77.31% +4.29% -0.50% +10.62% +1.82% +6.67% +3.66% n/a
United States Revenue 1.24B 1.29B 1.20B 975.60M 814.70M n/a n/a n/a n/a n/a n/a n/a
United States Revenue Growth -3.73% +7.39% +22.80% +19.75% n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 83.50M 83.00M 86.70M 90.00M 89.00M 88.40M 86.00M 85.70M 66.30M 81.50M 83.40M 98.00M 91.90M 92.70M 80.20M 76.30M 76.20M 77.70M 71.80M 69.00M 64.80M 70.30M 68.60M 59.70M 64.90M 70.00M 68.30M 58.90M 61.50M 60.60M 61.60M 60.90M 58.30M 62.50M 58.10M 62.40M 54.60M 71.70M 55.20M
Selling, General, and Administrative Revenue Growth +0.60% -4.27% -3.67% +1.12% +0.68% +2.79% +0.35% +29.26% -18.65% -2.28% -14.90% +6.64% -0.86% +15.59% +5.11% +0.13% -1.93% +8.22% +4.06% +6.48% -7.82% +2.48% +14.91% -8.01% -7.29% +2.49% +15.96% -4.23% +1.49% -1.62% +1.15% +4.46% -6.72% +7.57% -6.89% +14.29% -23.85% +29.89% n/a
Research and Development Revenue 15.50M 17.50M 17.60M 18.40M 16.40M 16.50M 17.10M 15.90M 13.60M 14.40M 14.60M 13.70M 13.10M 13.80M 12.20M 12.90M 12.50M 10.80M 10.70M 10.20M 9.30M 9.60M 9.80M 9.80M 10.10M 10.80M 9.60M 9.70M 9.10M 10.00M 10.30M 9.60M 9.00M 8.80M 9.40M 10.00M 8.50M 8.10M 7.50M
Research and Development Revenue Growth -11.43% -0.57% -4.35% +12.20% -0.61% -3.51% +7.55% +16.91% -5.56% -1.37% +6.57% +4.58% -5.07% +13.11% -5.43% +3.20% +15.74% +0.93% +4.90% +9.68% -3.12% -2.04% n/a -2.97% -6.48% +12.50% -1.03% +6.59% -9.00% -2.91% +7.29% +6.67% +2.27% -6.38% -6.00% +17.65% +4.94% +8.00% n/a